Despite significant investment in addiction treatment, drug-related overdose deaths in the U.S. continue to be alarmingly high.
Providers struggle to treat SUD patients due to relapse risks, treatment resistance, and associated behavioral health issues. Misrepresentation of substance use by patients and the high demand for care further strain their time and resources.